DrugPatentWatch Database Preview
Cannabidiol - Generic Drug Details
» See Plans and Pricing
What are the generic sources for cannabidiol and what is the scope of patent protection?
Cannabidiol
is the generic ingredient in one branded drug marketed by Gw Res Ltd and is included in one NDA. There are fourteen patents protecting this compound. Additional information is available in the individual branded drug profile pages.Cannabidiol has seventy-eight patent family members in twenty-one countries.
There are nine drug master file entries for cannabidiol. One supplier is listed for this compound.
Summary for cannabidiol
| International Patents: | 78 |
| US Patents: | 14 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 9 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 35 |
| Clinical Trials: | 208 |
| Patent Applications: | 4,916 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for cannabidiol |
| DailyMed Link: | cannabidiol at DailyMed |
Recent Clinical Trials for cannabidiol
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Jamie Burr | Early Phase 1 |
| The University of Texas Health Science Center at San Antonio | Phase 1/Phase 2 |
| National Center for Complementary and Integrative Health (NCCIH) | Phase 2 |
US Patents and Regulatory Information for cannabidiol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for cannabidiol
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| New Zealand | 529360 | Start Trial |
| Croatia | P20201230 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2016203239 | Start Trial |
| United Kingdom | 0409385 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
